Cambridge Healthtech Institute and Bio-IT World's
TCGC: The Clinical Genome Conference
Advances in Clinical Genome Sequencing, Diagnostics and Interpretation
______________________________________________________
June 12-13, 2012 | Hotel Kabuki | San Francisco, CA | http://healthtech.com/The-Clinical-Genome-Conference
View preliminary agenda: http://bit.ly/clg-brochure
Register now to SAVE up to $450! http://bit.ly/clg-reg
Cambridge Healthtech Institute and Bio-IT World are proud to announce TCGC: The Clinical Genome Conference, inviting stakeholders from all arenas impacting clinical genomics to share new findings and solutions in advancing the application of clinical genome sequencing.
______________________________________________________
PRE-CONFERENCE SHORT COURSES
June 11, 2011
- The Diagnostic Odyssey for Whole Genome Sequencing
- The Saga of Genomic Interpretation for Physicians, Payers, Patients
______________________________________________________
TRANSLATIONAL GENOMICS: BRIDGING THE GAP BETWEEN BENCH AND BEDSIDE
» PLENARY KEYNOTES
Whole Genome Sequencing - It's Just another Lab Value
Howard J. Jacob, Ph.D., Professor & Director, Human & Molecular Genetics Center, Medical College of Wisconsin
Translational Genomics and Health Outcomes: The Path to Genomic Medicine
Robert C. Green, M.D., MPH, Associate Director for Research, Partners Center for Personalized Genetic Medicine, Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School
Data-Driven Personalized Medicine
Atul Butte, M.D., Ph.D., Chief, Division of Systems Medicine, Department of Pediatrics; Associate Professor, Stanford University School of Medicine; Director, Center for Pediatric Bioinformatics, Lucile Packard Children's Hospital
» DISTINGUISHED FACULTY
The Vision and the Reality: One Cancer Center's Journey toward Genomic Medicine
Jeff Boyd, Ph.D., Senior Vice President, Molecular Medicine,The Robert C. Young, M.D., Chair in Cancer Research; Executive Director, Cancer Genome Institute; Chief, Division of Molecular Pathology, Professor and Co-Leader, Women's Cancer Program, Fox Chase Cancer Center
Whole Genome Analysis: Efficacy, Accuracy, and Application in Best Practice Care
Peter J. Tonellato, Ph.D., Director, Laboratory for Personalized Medicine, Center for Biomedical Informatics, and Professor (visiting), Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School
Progress in Building a Comprehensive Information and Technology Infrastructure for Whole Transcriptome RNA-Seq and Targeted Mutation Analysis across Large Populations of Cancer Patents
Randy Scott, Ph.D., Executive Chairman, Genomic Health
CONCURRENT BREAKOUT SESSIONS:
» REGULATION/CERTIFICATION/REIMBURSEMENT
» CONSUMER GENOMICS
» ETHICS
GENOME INTERPRETATION SOFTWARE SOLUTIONS
THE CLINICAL GENOME TECHNOLOGY SHOWCASE
The success of producing A's,C's,G's, and T's at exponentially lower costs along with longer and more accurate reads, is revolutionizing genomic diagnostic medicine. Thus, the promise of next-generation sequencing has shifted from discovery to clinical utility. Now the question is how best to use this sequence information in patient care? Here first hand from those companies that continue to drive the genomics revolution.
Complete Genomics
Additional Companies to be Announced
______________________________________________________
View preliminary agenda: http://bit.ly/clg-brochure
Register by March 16 to SAVE up to $450! http://bit.ly/clg-reg
______________________________________________________
TCGC: The Clinical Genome Conference
Advances in Clinical Genome Sequencing, Diagnostics and Interpretation
______________________________________________________
June 12-13, 2012 | Hotel Kabuki | San Francisco, CA | http://healthtech.com/The-Clinical-Genome-Conference
View preliminary agenda: http://bit.ly/clg-brochure
Register now to SAVE up to $450! http://bit.ly/clg-reg
Cambridge Healthtech Institute and Bio-IT World are proud to announce TCGC: The Clinical Genome Conference, inviting stakeholders from all arenas impacting clinical genomics to share new findings and solutions in advancing the application of clinical genome sequencing.
______________________________________________________
PRE-CONFERENCE SHORT COURSES
June 11, 2011
- The Diagnostic Odyssey for Whole Genome Sequencing
- The Saga of Genomic Interpretation for Physicians, Payers, Patients
______________________________________________________
TRANSLATIONAL GENOMICS: BRIDGING THE GAP BETWEEN BENCH AND BEDSIDE
» PLENARY KEYNOTES
Whole Genome Sequencing - It's Just another Lab Value
Howard J. Jacob, Ph.D., Professor & Director, Human & Molecular Genetics Center, Medical College of Wisconsin
Translational Genomics and Health Outcomes: The Path to Genomic Medicine
Robert C. Green, M.D., MPH, Associate Director for Research, Partners Center for Personalized Genetic Medicine, Division of Genetics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School
Data-Driven Personalized Medicine
Atul Butte, M.D., Ph.D., Chief, Division of Systems Medicine, Department of Pediatrics; Associate Professor, Stanford University School of Medicine; Director, Center for Pediatric Bioinformatics, Lucile Packard Children's Hospital
» DISTINGUISHED FACULTY
The Vision and the Reality: One Cancer Center's Journey toward Genomic Medicine
Jeff Boyd, Ph.D., Senior Vice President, Molecular Medicine,The Robert C. Young, M.D., Chair in Cancer Research; Executive Director, Cancer Genome Institute; Chief, Division of Molecular Pathology, Professor and Co-Leader, Women's Cancer Program, Fox Chase Cancer Center
Whole Genome Analysis: Efficacy, Accuracy, and Application in Best Practice Care
Peter J. Tonellato, Ph.D., Director, Laboratory for Personalized Medicine, Center for Biomedical Informatics, and Professor (visiting), Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School
Progress in Building a Comprehensive Information and Technology Infrastructure for Whole Transcriptome RNA-Seq and Targeted Mutation Analysis across Large Populations of Cancer Patents
Randy Scott, Ph.D., Executive Chairman, Genomic Health
CONCURRENT BREAKOUT SESSIONS:
» REGULATION/CERTIFICATION/REIMBURSEMENT
» CONSUMER GENOMICS
» ETHICS
GENOME INTERPRETATION SOFTWARE SOLUTIONS
THE CLINICAL GENOME TECHNOLOGY SHOWCASE
The success of producing A's,C's,G's, and T's at exponentially lower costs along with longer and more accurate reads, is revolutionizing genomic diagnostic medicine. Thus, the promise of next-generation sequencing has shifted from discovery to clinical utility. Now the question is how best to use this sequence information in patient care? Here first hand from those companies that continue to drive the genomics revolution.
Complete Genomics
Additional Companies to be Announced
______________________________________________________
View preliminary agenda: http://bit.ly/clg-brochure
Register by March 16 to SAVE up to $450! http://bit.ly/clg-reg
______________________________________________________
